Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.
Frequently asked questions
What sector does Vitrolife AB (VITR) operate in?
Vitrolife AB belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Vitrolife AB (VITR) current stock price?
As of the latest data, Vitrolife AB stock price is SEK 92.70, with a previous close of SEK 91.85. Vitrolife AB gained SEK 0.85 in the last trading session, representing a 0.93% increase.
What is Vitrolife AB (VITR) current market capitalization?
Vitrolife AB market cap is approximately 12.56 billion.
What is Vitrolife AB (VITR) Earnings Per Share (EPS)?
The trailing EPS is -SEK 36.80, and the forward EPS is SEK 5.25.
What is Vitrolife AB (VITR) EBITDA?
Vitrolife AB EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 258.00 million.
Does Vitrolife AB (VITR) pay dividends?
Yes. Vitrolife AB pays annual dividends with an annualized yield of 1.19% and an estimated annual payout of SEK 1.10 per share.
When is the next ex-dividend date for Vitrolife AB (VITR)?
The next ex-dividend date is scheduled for May 06, 2027.
How did Vitrolife AB (VITR) perform in its most recent earnings report?
In the last report (June 30, 2026), Vitrolife AB posted an EPS surprise of 15.85% and a revenue surprise of -2.68%.
What is Vitrolife AB (VITR) beta (volatility) score?
Vitrolife AB has a beta of 1.722, suggesting it is more volatile than the market.
